Peskin Pharmaceuticals® follows the new medicament paradigm. Instead of blocking or impeding metabolic pathways, we seek to optimize them, as appropriate.
Once inflammation is reduced, healing accelerates, naturally. We are in the forefront of this groundbreaking science.
EZTREK® is not a medicine and is not intended to treat, diagnose, mitigate, prevent, or cure diseases.
Based on over 25 years of state-of-the-art medical research, our mission is to bring to market plant-based lipids formulations utilizing state-of-the-art lipids physiology. We specialize in the research of plant-based lipid sources in unique ways that are not chemically synthesized.
Our unique focus is helping to compensate for an impaired Δ-6 Desaturase Metabolic Pathway to help decrease inflammation. This pathway is impaired in numerous patient populations, as evaluated by your physician.
EZTREK® Medical Food: After twenty years in development, this is the 1st Medical Food we are aware of, that is designed to help compensate for impaired delta-6 desaturase (D6D) metabolic pathways.